DoGusign Envelope ID.. A1B3A320-1BC944D9-AEBD-AE2D6F204600
Charity Registration No. 1182637 {England and Wales)
Charity Registration No. SC049948 (Scotlandl
Company Registration No. CE016951 {England and Wales)
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT AND
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2023

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
David Oxnam (Chair of Board of Trustees)
Gayle Routledge
Rachel Wilcox
David Hobin
Sarah Curtis
Chief Executive
Ashley Ball-Gamble
Charity number
1182637 (England and Wales)
SC049948 (Scotlandl
Company numbèr
CE016951
Operating name
CCLG
Principal address
Century House
24 De Monrfort Street
Leicester
LE17GB
Auditor
Newby Caslleman LLP
West Walk Building
110 Regent Road
Leicester
LE17LT
Bankers
HSBC Bank Pl¢
2-6 Gallowtree Gate
Leicester
LE1 1DA
Scottish Widows Bank PIC
PO Box 12757
67 Morrison Street
Edinburgh
EH3 8YJ
CAF Bank Ltd
25 Kings Avenue
Kings Hill
Kent
ME194JQ

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
CONTENTS
Page
Trustees. report
Independent audilorfs ￿port
11- 13
ststement of financial a¢livilies
14
Balan￿ sheet
15
Statement of cash flows
16
Notes to the financial slalements

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 DECEMBER 2023
The trustees of The Children's Cancer and Leukaemia Group are pleased to present their annual report and
financial statements for the year ended 31 De￿rnber 2023.
The financial statements have been prepared in accordance with the accounting policies set out in the notes
to the accounts and comply with the charity's governing document, the Financial Reporting Standard
applicable in the United Kingdom and Republic of Ireland {"FRS 1021, Accounting and Reporting by Charities..
the Statement of Recommended Practice for charities applying FRS 102120191, the Charities Act 2011, the
Charities and Trustee Investment Iscotlandl Act 2005, and UK Generally Accepted Accounting Pracbce.
OBJECTIVES AND ACTIVITIES
The objectives of The child￿n'S Cancer and Leukaemia Group ICCLGI as defined in the constitution are..
For the public benefit. the relief of sickness and suffering of children. teenagers and young aduhs with cancer
and advancement of education in the field of children, teenagers and young adults with cancer, in particular
but not exclusively by..
1. The relief of sickness and promotion and protection of good health by supporting research into the nature,
causes, diagnosis, treatment and social consequences of cancer in children, teenagers and young adults,
and lo publish the useful results of such research.
2. The relief of suffering of children, teenagers and young adults with cancer and their families and carers,
through the provision of information and support services lo them.
3. The advancement of the education of the public in all areas relating lo cancer in children, teenagers and
young adults.
4. The advancement of education and clinical practi￿ by the dissemination of knowledge of the latest
research and best practi￿ amongst professionals and practitioners engaged in the treatment, care and
support of children, teenagers and young adults with Can￿r.
The main beneficiaries of the work carried out by the charity are children, teenagers and young adults with
cancer and their families in the United Kingdom and elsewhere in the world.
CCLG is the UK and Ireland's professional association forall those involved in the treatment, care and research
of children and young people (aged 0-251 with cancer. Al the end of 2023, our membership had grown to more
than 1,500 members. We also operate 'Teenagers and Young Adutts with Cancer, ITYACI, a specific
membership group for those working with young people aged 13-25 with a cancer diagnosis, which had over
470 members al the end of the year.
We support our professional members to network, share best practice, advance education, and our activities
aim to ensure every child with cancer receives the best possible treatment and care, wherever they live.
Vve carry out a wide range of activities to support our professional members, including..
Member interest groups, bringing together professionals working in the same professional group, or with
shared clinical or research interests. to develop treatment and care guidelines, to deliver education. to
initiate research projects and to develop ￿SoUrceS for use by other professionals.
We deliver a range of meetings and educational events each year to ensure members are kept up to date
with the latest developments in care, treatment and research. Our flagship annual meeting provides an
opportunity for all of our members to network with colleagues from across the UK and Ireland, share best
practice and leam about new innovations and initiatives.
Professional voice for children, teenagers and young adults.. We advise govemments and other bodies
and ensure that we are represented on important groups or in consultations, for example in the area of
NHS commissioning of children's cancer services or the development of NICE quality standards and
guidance.
Our member website is a vital hub for professionals, providing a wealth of resources and educational
opportunities, complemented by our new online member community, allowing networking and good
practice sharing opportunities beyond group meetings and events.
Our members are dedicated to ensuring that children and young people have a greater chance of survival and
a belter lrfe after Ire8tmenl.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
We support children and young people with cancer and their families in a variety of different ways..
Written by experts. our comprehensive quality-assured range of information booklets, leaflets and online
content helps patients and their families understand their diagnosis, treatment and what to expect now
and in the future. Our publications are available free of charge to those who need them.
Our free quarterly magazine, Contact, offers help, support and information for families of children,
teenagers and young adults with cancer.
Our online community provides a 'safe space, for parents of children with cancer to come together and
share experiences, ask for advice, and, uniquely, ask expert questions of our professional membership.
Our website is a comprehensive resource of childhood cancer information, providing a wide range of up-
to-date expert information, personal stories and more.
The outstanding progress made in cancer treatment is the result of extensive research studies and clinical
trials over the last 50 years which now underpin today's standard treatments. During this time. CCLG has
played a key role in the success seen in the wodd of children's cancer so that now over 800/0 of children are
cured. Bul there are still some childhood cancers with a poor outlook, and some treatments can have long-
lasting and devastating side effects. Further research is vital to improve survival rates and lo fi'nd kinder
treatments. We fund and support a variety of research into childhood cancers including..
We offer funds and grants lo launch new research projeds and develop new clinical trials.
We work in partnership with other charities and organisations to support research. We use our research
funding infrastructure, as well as the scientific and medical expertise of our membership, lo support
smaller charities lo meet their research aims. For example, by managing a research funding programme
or helping them lo identify research to support.
We can 'ringfence' funds so that our supporters can raise funds towards a cancer-specific research
project.
Our Special Interest Groups provide a forum for discussion and planning of research and bring together
potential collaborators. We organise and support scientific meetings where research findings are shared
and discussed, and we support our membership lo be involved in planning research and attending
important meetings through bursaries and sponsorship.
During the year, following the closure of the National Cancer Research Inslilule INCRII we took over
hosting the Children's Research Group and Teenage and Young Adult & Germ Cell Tumour Research
Group, along with their subgroups, which sel UK research strategy. develop new studies and drive forward
the research agenda.
sin￿ 2017, CCLG has been a member of the Association of Medical Research Charities, demonstrating
our commitment to funding high-qualily, world class research and confirming the high standard of the
processes we use to select and fund research.
We measure our success in achieving OLJr objectives in a number of ways..
The number of patient information products distributed, and the number of visits to the 'about childhood
cancerf section of our website, are some measures used to ascertain our success in supporting patients
and their families. We also gather feedback on OLJr information products.
The number of members and retention of members are some basic measures used to ascertain how w8
are supporting the community of professionals we serve through our professional association activities.
The number of research projects funded and their value, and the outcome of research projects including
peer-reviewed papers in scientific journals, and the number of projects that led lo further funding from
ourselves or another research funder.
We have now begun developing our new strategic plan, sel to launch in 2025. As part of this work, we
will consider how we beller measure and report on our impact.
ACHIEVEMENTS AND PERFORMANCE
Around 1,800 children laged 0-14} and a fLJrther 2,300 teenagers and young adults (aged 15-251 are diagnosed
with can¢er ea¢h year in the UK. Alhough overall five-year survival for cancer in children and young people is
, for some cancers there have not been such dramatic improvements in survival, and even where
treatment is successful, many survivors have to contend with life-long and Iife-limiting side effects. Vve continue
to work towards the four main goals set out in OLJr strategic plan, launched in 2018, and the goals of the TYAC
strategic plan, launched in 2019, as detailed below. Highlights of our achievements during the year are set out
under each of these strategic goals.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Providin
leadershi
and ex
ertise for the treatment and care of children and
oun
eo le wtth cancer
As the UK and Ireland's professional association for those working in the field of paediatric oncology and
h8ematology, CCLG is a leading voice for children's cancer, liaising with community groups, the government
and the NHS to influence policies. We use our expertise to improve treatment and care and meet the needs
of patients and families. Highlights for 2023 include..
We hosted the laryesl ever CCLG Annual Collferen￿ in March, bringing together more than 450
professionals to share best practice, hear about the latest research and developments, and network with
colleagues. For the first lime, the Conferen￿ included dedicated teenage and young adult cancer
sessions, as well as parallel sessions for our mulliprofessional membership.
The Annual Conference also saw the retum of the CCLG Member Awards for the second year,
recognising dedication and excellence amongst our professional community.
We held a number of other in-person educational opportunities for members during the year, including a
two4ay specialist course in renal lumours, as well as expanding our online webinar series.
We continued to produce and update a number of clinical treatment guidelines, ensuring standardised,
high quality and evidence-based Ireatrnent for all children, particulady in diseases where there is currently
no open clinical trial.
Launch at the end of 2022, CCLG Connect, an online community for the CCLG membership, continued
to grow and see increased engagement from the membership. CCLG Connect provides a space for
members to connect with each other, participate in group activities, share besl-praclice and research
outputs. ask questions and disseminate useful resources. So far, feedback on this new resource has been
hugely positive.
Our strategic partnership with Young Lives vs Cancer continued, providing benefits to both organisalions.
The Chief Nurse role al CCLG is funded by Young Lives vs Cancer, working to provide clinical and health
system insight and intelligence to the laller and enhance support for nursing and 811ied health
professionals within CCLG.
With Young Lives vs Cancer, we called on the government to publish a 10-year cancer plan for children
and young people, lo ensure that their unique and critical needs are recognised, understood. and
addressed. We want lo work together as a sector with the Department of Health and Social Care lo see
a fully resourced, long-term strategy pul in place lo provide the care and support needed to radically
improve eXperIen￿S and outcomes for children and young people with cancer.
In partnership with Young Lives vs Cancer, the Ellen MacArthur Cancer Trust, and Teenage Cancer Trust,
we commissioned a gmund-breaking piece of research that will build a new evidence base looking at the
psychosocial needs of young can￿r patients and how the current system supports them. The research
will also identify gaps and what needs lo happen in order to build a better future for children and young
people diagnosed with cancer. Dartington Service Design Lab, a charity which improves children's
outcomes through research, systems thinking and co4esign approaches, was commissioned as the
research partner. They undertook experience-led research, co-designed by young people, parents of
children with cancer, and key stakeholders. The aim of the research is to improve policies and practice
around cancer support and will be published in 2024.
We18unched the first in a series of e-learning units to support the development of multiprofessionals in
the early years of a career in children or teenage and young adult cancer services. The full sel of nine
units will form a foundation course called 'An introduction lo cancer in a child, teenager and young adult,
and the remaining units will all be available by the end of 2024. The aim is to improve options and access
to foundation level leaming in a timely way, in a formal where learners can choose their own schedule of
learning.
rovin
dia
nosis limes b
increasin
awareness
The significance of a delayed diagnosis presents a challenge for primary health care professionals, who are
required lo triage symptoms that may point to a cancer diagnosis and make appropriate onward referrals.
Many symptoms associated with cancer are non-specific and are seen every day in general practice, whilst a
cancer diagnosis is seen infrequently.
Delays in the diagnostic pathway may well lead lo more advanced disease at presentation, with subsequent
greater risk of death, greater morbidity, and inevitably, distrust of the medical system. There is evidence that
tumours presenting in childhood in the UK are larger, at a more advanced stage and require more therapy

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
than those presenting in other parts of Europe. We work to improve diagnosis times for children and young
people with cancer. In 2023..
We continued working on our Child Cancer Smart project. which will result in a number of clinical referral
guidelines, and public and professional awareness tools, on the signs and symptoms of childhood cancer.
Work to date has comprised a significant amount of research to understand the signs and symptoms of
childhood cancer, providing an evidence-based approach, for the first lime, lo developing tools lo support
medical professionals in making a diagnosis, as well as a series of public campaigns to raise awareness
of the signs and symptoms of childhood cancer. We expect lo launch the first tools and campaigns during
2024.
The Child Cancer Diagnosis Study, a research project funded by the National Institute for Health
Research INIHR) and CCLG, and jointly run by CCLG and The University of Nollingham, closed and the
analysis of the data began. This innovative, nationwide research will give us. for the first lime, an accurate
picture of the routes lo diagnosis and where we can develop inlervenlions to drive improvements.
We published research that shows only 320/0 of adult survey respondents fell confident in recognising
cancer signs and symptoms in children, teenagers and young adults. The survey results demonslraled
th8t most of the respondents underestimated the risk of cancer in children, selected symptoms associated
with adult, rather than childhood cancers, and didn't recognise that disturbed growih or pubertal
development were indicators of childhood ill health. Using these results, we can put inlervenlions in place
to improve awareness and knowledge amongst the general public, including targeted information for
rtain groups, including healthcare professionals lo accelerate diagnosis. This data will be crucial lo
informing the Child Cancer Smart awareness campaign, providing information about gaps in public
awareness and knowledge which we can address through messaging in the campaign.
Stren
Ihenin
our ex
ert information
ortlolio to su
ort more families of a child with cancer
Looking after a child with canTrr Can be a scary and lonely experience for families. Our goal is to deliver the
right information at the right time and make a positive difference to their daily lives. We continue lo be the
leading provider of expert-writlen, award-winning and quality-assured information about all aspects of
childhood cancer, from diagnosis lo life when treatment has finished. In 2023..
We conlinued lo provide free information booklets and leaflets lo hospitals and directly lo families during
the year. A number of new publications were produced, and further existing publications were reviewed
and revised.
We produced four issues of our popular magazine, Contsct. Feedback on the new fomal and design,
launched in 2021, continues lo be overwhelmingly positive, and Contact continues lo support families
across the UK and around the world.
We continued our series of online 'research talks, aimed al parents of children with cancer land the
general publicl, which aim to explore the world of childhood can￿r research in an accessible way, with
each episode in the series featuring a talk from an expert speaker, as well as the opportunity for allendees
lo ask questions. Recordings of the webinars are made available on our YouTube channel for those
unable to attend the live events.
Our closed Facebook group for parents and carers of children with cancer, which allows members lo seek
advice and support from those with similar experiences, and, uniquely, 'ask the experts, through posting
questions answered by our clinical membership community, continued to grow, reaching over 1,500
members.
We successfully passed our annual reassessment for the Patient Information Forum IPIFI PIFTick
accreditation for our health information. This quality standard is awarded following rigorous assessment
of our informalion production processes, and demonstrates our commitment lo reliable, expert, high-
quality health information.
ortin
and fundin
world-class research
Our aim is to both support and fund world-class research, deepen understanding and foster collaborations
across the childhood cancer community. One of our most important areas of work is to offer opportunities for
our members to develop scientific networks and belong to a wider research community dedicated to childhood
cancer.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Our Research Strategy outlines our exciting plans lo fund and support innovative world-c18ss research into
childhood cancer and recognises the Importan￿ of collaboration. both nationally and internationally, to
achieve improvements.
We fund research direcdy. and work with partner charities to support them to fund the best possible
research, using our well-established research funding expertise, experience and infrastructure. In total,
between our own research funding and that of the partners we work with, 30 new research projects
tolalling around £5.8 million were funded in 2023. Grants awarded cover a wide range of childhood cancer
types, projects focusing on different parts of the cancer experience, and covering a range of different
types of research.
Our partnership with The Little Princess Trust continues to go from strength lo strength. We support The
Little Princess Trust lo fund the best quality research, with a focus on finding better, kinder Irealments.
We provide specialist advice and expertise. as well as run and manage their research-funding programme
on their behalf. This partnership helps to minimise duplication, and share expertise meaning that
ullimalely more money is spent directly on research. During the year, the Little Princess Trust awarded
CCLG around £4.4 million lo fund innovative new research proposals. In September, our partnership with
The Little Princess Trust was recognised with a 'highly commended award, in the Charity Partnership of
the Year category al the Third Sector Awards.
During the year, we also made research grants on behalf of, and funded by, Candlelighters and The
Harley Staples Cancer Trust.
During the year, the National Cancer Research Institute INCRII, a UK-wide partnership between research
funders working together lo maximise the value and benefits of cancer research for patients and the
public, sadly announced its closure. As a, NCRI partner, CCLG stepped up lo offer support to the children
and young people elements of the NCRI'S work, allowing this vital work lo continue while a longer-tem
solution is sought. CCLG continues lo host the previous NCRI 'Children's' and 'Teenage and Young Adult
and Gemi Cell Tumour, research groups, which set the research agenda in these areas and contribute to
the development of research studies for our patients.
We continued lo publish our research blog, aiming lo make research understandable and a¢￿SSIble to
all those in the childhood cancer community and beyond, including parents, professionals and the general
public. The blog shares research concepts and specific projects in an accessible way, raising awareness
of both the research we undertake and of cancer research more generally.
In September, we hosted our first Research Discovery Day, to offer valuable insight into the research we
fund lo families and supporters. Among the allendees were parents of children diagnosed with cancer,
survivors and CCLG fundraisers, who were able lo hear experts from Birmingham Children's Hospital.
the University of Nollingham and the University of Oxford tslk about how they're working lo improve the
future for children with cancer. Before that, they heard from Emma Jones, whose daughter Ruby passed
away from blood cancer in 2020. Emma spoke about Ruby's wish to donate her life savings lo research
lo help other young can￿r patients, and why she carries on her daughter's legacy by raising money for
research through Ruby's Live Kindly Live Loudly Fund, a Special Named Fund at CCLG.
In December 2022, the final workshop of the Children's Cancer Priority Selling Partnership IPSPI, initiated
by CCLG and w-funded with The Little Princess Trust, look place and the Top 10 Priorities in Children's
Can￿r ReSea￿h were announced. In June, we launched the final report of the PSP with a special event.
The findings were presented al the launch event, which brought together charities, researchers and
research funders, as well as those affected by childhood cancer. Members of the project team spoke
about the importance of the PSP, while the audience heard from a childhoc>d can￿r survivor and parents
of childhood cancer patients about what the report means lo them. We continue lo work with partners to
ensure that the priorities identified by the PSP now influenTr research funding going fonmard, to ensure
that the needs of young cancer patients are reflected in research.
Teena
ers and Youn
Adults with Can￿r
r(AC
Teenagers and Young Adults with Cancer ITYACI is the professional association for those working in teenage
and young adult ITYAI oncology. TYAC merged with CCLG in 2018, and in 2019 we launched a new strategy
for the work of TYAC, selling out how we would continue lo drive improvements in TYA cancer care, and
support the development of professionals working in the field.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Fundraisin
All of our work is dependent on the generosity of our supporters. A programme of fundraising underpins our
ability to fund research, support patients and families, and improve treatment and care for children and young
people with cancer.
Our Special Named Fund programme continued lo grow. After their cancer experiences, families sometimes
consider setting up their own charity. For many, our Special Named Funds may be a great alternative. We
support families lo achieve their fundraising objectives, while taking away the administrative burden of setting
up and running a charity. Al the end of the year, there were approximately 98 Special Named Funds at CCLG
12022.. 851, each raising funds lo support research into a specific type of childhood cancer.
During the year, we began wort(ing on a new fundraising strategy, to be launched in 2024, which aims to
ensure we are able lo sustain our income growth and continue lo deliver on our charitable objectives.. funding
research, supporting families and ensuring that all young patients receive the best possible treatment and
care.
We are hugely grateful lo all those who chose lo support CCLG, by making a donation, taking part in an event,
or organising their own fundraiser during the year.
Fundraisin
We are reliant on donations lo fund our vital work. Without the generosity of the public, we would not be able
to continue providing support to children and young people diagnosed with cancer, and their families, nor fund
research into childhood cancer. We believe that it is essential that we are clear and open about how we raise
our funds and about the range of ways people can get involved and support our work.
People raise money for us in many different ways, including through taking part in sporting events. organising
events in their local Community, or fundraising at their place of work. We also provide opportunities for people
to fundraise through providing access lo places in key events, such as the London Marathon, and through
providing fundraising materials. Our supporters can sign up lo make regular donations, or play our lollery which
we launched in 2018.
We work with a number of corporate partners, and have received support from charitable trusts and
foundations, and through grants from other charities.
We do not carry out door-to-door fundraising, nor do we use street fundraising to sign up supporters to regular
donations.
Currently, none of our fundraising activities are condurted on our behalf by professional fundraising agencies.
CCLG is registered with the Fundraising Regulator. We are committed to adhering to the Code of Fundraising
Practice. During the year, we received no complaints about our fundraising activities.
Regular updates are provided to our board of trustees lo ensure that they have a good oversight of our
aclivilies.
FINANCIAL REVIEW
Transactions for the year ended 31 December 2023 fall into roughly the same categories as in previous years.
Income generally consists of donations and fundraising income, subscriptions {comprising individual
membership subscriptions and hospital subscriptions for health inform8tionl, registration fees for meetings and
events, funding from partner charities such as The Little Princess Trust lo support research projects, and
legacy income. We are grateful lo Young Lives vs Cancer, Teenage Cancer Trust and The Little Princess Trust
for their support of specific areas of our work. We also benefitted from a grant from The Medical Research
Council UK Government COVID Medical Research Charity Support Fund, a scheme designed lo support
fundraising medical research charities who fund early-career researchers in response lo the COVID-19
pandemic.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
The major items of expenditure for CCLG remain staff salaries, professional meeting and event costs, the
costs associated with the production of health information, and the awarding of research grants. Staffing costs
represent a significant financial commitment, but our small, expert staff team is also responsible for the
achievement of the majority of our charitsble objectives. Staffing levels are kept under review, with the small,
efficient team carrying out and coordinating the considerable activities of the charity.
Our overall income increased by £167,538, compared with the year ending December 2022. There was a
small decrease in donations for the year, and an increase in income from meeting registration fees as more
events were held in-person following the reduction in number over the past few years caused by the COVID-
19 pandemic.
CCLG has a number of restricted funds. Internal records are kept according to requirements for restriction, i.e.
disease-specific donations for research into a specific type of can￿r, or donations for a specific piece of work.
The reslricled funds are ring-fenced lo support specific projects or areas of adivily and cannot be used lo
support the general running costs of the organisation.
Expenditure decreased in 2023 by £122,277 compared to 2022. While our expenditure on research decreased,
expenditure increased slightly on our health information and professional body activities.
We ended the year with an overall surplus of £827,665. There was a deficit in unrestricted incomelexpendilure
of £101,002, which was planned and represents the Trustees commitment to invest reserves held above the
level of our reserves policy into our charitable aclivilies. There was a surplus in restricted incomelexpenditure
of £928,657. Much of our reslricled funding is for research, and often funds build over several years before
being expended in significant amounts to fund research projects. We plan to invest a significant amount of
restricted funds in the next 12 months.
Reserves Polic
The trustees continue to consider the appropriate balance of financial stability and investment in charitsble
aclivily. The COVID-19 pandemic has highlighted the importance of an appropriate reserves policy. 11 is
important we continue lo hold a level of reserves which can sustain our activity until we have a fuller picture of
what posl-pandemic fundraising might look like in the medium-term.
We have plans in place to ensure CCLG is 'fil for the future, and our reserves policy will ensure we are able to
meet those plans. Al the end of the year, we have reviewed our reserves policy for CCLG and aim lo hold a
target level of free reserves lunreslricted funds less tangible fixed asselsl of £400,000, which the trustees
consider lo be approximately six months of core expenditure, including staff salaries, accommodation costs
and general running costs. Total reserves at 31 December 2023 were £3,288,552 of which £2,898,594 are
restricted and £389,958 are unreslricled. As al 31 De￿mber 2023 the charity's free reserves tolalled £358,954
which is just below the reserves policy. Given the current economic uncertainty, the Iruslees consider it prudent
to balance the investment of reserves into our charitable activity whilst ensuring sufficient funds are available
to ensure the charity is a 'going con¢em' and able to meet ils ¢ommilments. The Trustees continue to keep
the reserves policy under review lo ensure that CCLG is 'fit for the future,.
Our restricted reserves appear high, at £2,898,594 al the end of 2023. Much of our restricted fundraising
income is raised by families. ring-fenced for research into specific types of childhood cancer. Research
requires significant investment, and thus many of our funds grow over the course of several years before a
large sum of money is awarded in the form of a research grant. Our restricted reserves comprise a large
number of specific restricted hjnds which are ring-fenced lo a specific purpose, and therefore cannot be used
for general aclivilies. Levels of funds are reviewed on a regular basis and spent on charitsble activities as soon
as sufficient funds are available. We are planning lo invest a significant amount of reslricled reserves into
research during 2024.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Investment olic
The Trustees previously reviewed our plans for investments lo consider the most appropriate way of managing
these, balancing cashflow, risk and reward. Given the ongoing uncertainly ofthe financial impact ofthe COVID-
19 pandemic, and the cost-of-living crisis and high inflation, no further action has been taken on investments.
The high interest rates during the year have resulted in increased investment returns in the form of interest on
money held in our bank accounts. Management accounts are produced for the trustees, and a cashflow
forecast considerably facilitates management and prediction of charity income.
Risk Mana
ement
CCLG is also aware of the requirement to carry out a risk review of ils aclivilies. The trustees reviewed the
risks the charity faces during the year. A Risk Register is in operation, documenting the systems in place to
mitigate those risks, and is kept under review by the trustees.
FUTURE ACTIVITIES
All future activities planned are designed lo ensLJre that CCLG continues to fulfil its objectives for children and
young people with cancer. and their families, as the ultimate beneficiaries. As the membership of CCLG
continues lo grow. so does the activity our members are involved in. Our specialist network groups continue
to be increasingly active, supporting our activities and providing specialist advice to commissioners of
healthcare services and others. The Executive continues to consider ways that CCLG can advance education
and professional development, and share and guide best practice.
Key planned activity for the next 12 months includes..
Researching, designing, building and launching a new website.
Merging the CCLG and TYAC memberships into a single membership body, for professionals wort(ing in
the field of childhood andlor teenage and yOLJng adult cancers. This will increase the range of support
available for members and enabling the resources currently used to maintain two membership functions
to be reinvested into other activities.
Towards the end of the year, we will launch a refreshed brand for the organisation, that better articulates
the wide range of activities we are involved in, reflects that the organisation works across the 0-25 age
range, and engages a larger number of supporters. This will include the launch of a new website that
uses more modern technology and better meets the needs of our various audiences.
We will develop and launch a new research strategy, which reflects our position as a leader in setting the
research agenda, and aligns our funding work with the Top 10 Research Priorities for Children's Cancer
identified through the Children's Cancer Priority Setting Partnership. A key aim of the strategy will be
increasing collaborative and partnership working across the sector to ensure more world-class research
is funded, more quickly.
Reviewing our health information content and increasing the range of content available in alternative
formals, in particular videos, to beller meet the needs of our intended users
We will launch the first guidelines, clinical decision tools and public awareness campaigns from our Child
Can￿r Smart work, raising awareness of the signs and symptoms of cancer in children and young people,
and equipping healthcare professionals to make qLJicker diagnoses.
STRUCTURE GOVERNANCE AND MANAGEMENT
The Children's Cancer and Leukaemia Group ICCLGI was established in 1977 and became a registered
charity Inumber 2866691 in 1983. In 2019, a new CIO Iregislration number 11826371 was fomed. with the
aclivilies, assets and liabilities of the previous charity transferred to the CIO.
The charity s governing instrument is the Constitution and the CIO was first registered in February 2019. In
2020, the CIO became registered with the Scottish Charity Regulator Iregistration number SC0499481.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
The board of trustees is independent of the CCLG membership. The board of trustees is responsible for
managing the charity finances in support of the objectives defined by the CCLG Executive. There are a
minimum of two and a maximum of eight Iruslees. One of the Iruslees will be an elected member of the CCLG
Executive. providing a link between these two groups.
If a vacancy arises, the Iruslees may appoint any eligible person as a trustee. In selecting individuals for
appointment as trustees, the trustees will consider the skills, knowledge and experience needed for the
effective running of the charity. Upon appointment, Iruslees are provided with an induction to the charity. This
consists of a briefing paper, as well as meetings with the Chair, CEO, and others as deemed appropriate.
Regard is given lo the training and development needs of any trustees that may arise. The board of Iruslees
meets quarterly and is supported by slaff. Four meetings were held in 2023.
The Iruslees come from a range of professional backgrounds, and bring new skills and highly relevant
experience. Trustees serving during the year were..
David Oxn2m (Chair of Board of Trusleesl
Gayle Routledge
Rachel Wilcox
David Hobin
Sarah Curtis
The Chief Executive is responsible for the day-to-day operation of the charity on behalf of the trustees. The
remuneration of key management is reviewed annually and is set against established pay scales,
benchmarked in comparison with similar sized entities including both charities and medical professional
associations. The trustees give their lime freely and no remuneration was paid in the year. Details of trustee
expenses are disclosed in note 12 to the accounts.
Key Management Personnel during the year were..
Ashley Ball-Gamble Ichief Execulivel
Vicki Brunt (Head of Fundraising)
Claire Shinfield (Head of Engagement)
Jeanette Hawkins (Chief Nurse)
STATEMENT OF TRUSTEES. RESPONSIBILITIES
The trustees are responsible for preparing the Trustees, Report and the financial statements in accordance
with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted
Accounting Practi￿1.
The law applicable to charities in England & Wales and Scotland requires the Iruslees lo prepare financial
ststements for each financial year which give a true and fair view of the slate of affairs of the charity and of the
incoming resources and application of resour￿$ of the charity for that period. In preparing these financial
stalemenls, the Iruslees are required lo:
select suitable accounting policies and then apply them consislenlly.,
observe the methods and principles in the Charities SORP 2019 IFRS 1021.,
make judgements and estimates that are reasonable and prudent.,
stale whether applicable accounting standards have been followed, subject to any m8terial departures
disclosed and explained in the financial slatemenls.,
prepare the financial statements on the going concem basis unless it is inappropriate lo presume that the
charity will continue in operation.
The Iruslees are responsible for keeping proper accounting records that disclose with reasonable accuracy al
any lime the financial position of the charity and enable them to ensure that the financial statements comply
with the Charities Act 2011, the Charities and Trustee Investment (Scollandl Act 2005, the Charities (Accounts
and Reports) Regulations 2008, the Charities Accounts (Scollandl Regulations 2006 las amended) and the
provisions of the charity's constitution. They are also responsible for safeguarding the assets of the charity
and hence for tsking reasonable steps for the prevention and detection of fraud and other irregularities.

Docusign Envelope ID." A1B3A320-1BCW44D9-AEBt>AE2D6F204600
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
The trustees are responsible for the maintenance and integrity of the charity and financial information included
on the charity s website. Legislation in the United Kingdom governing the preparation and dissemination of
financial statements may differ from legislation in other jurisdictions.
Do¢uSWid by..
29DQBSFD6U71VX.
David Oxnam
Chair of the board of trustees
16-08-2024
Date..
10-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
INDEPENDENT AUDITOR'S REPORT
TO THE TRUSTEES OF THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
Opinion
We have audited the financial slalements of The Children's Cancer and Leukaemia Group Ilhe 'charily'l for the year
ended 31 December 2023 which cornprise the slalement of financial aclivilies, the balance sheet, the slalement of
cash flows and notes lo the financial slalements, including significant accounting policies. The financial reporting
framework that has been applied in their preparation is applicable law and United Kingdom A¢¢ounling Standards,
including Financial Reporting Standard 102 The Fiftancial Reporting Standard applicable in the UK and Republic ol
I￿land (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial ststemonls..
give a true and fair view of the state of the charity's affairs as at 31 December 2023 and of its incoming
resources and application of resources, for the year then ended.,
h8ve been propedy prepared in 8¢cord8nce with United Kingdom Generally Accepted Accounting Practi￿.,
and
have been prepared in accordance with the requirements of the Charities Act 2011, the Charities and Trustee
Investment (Scotlandl Act 2005 and regulation 8 of the Charities Accounts (Scotlandl Regulations 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing IUKI IISAS IUKII and applicable
law. Our responsibilities under those standards are further described in the Audilorfs responsibilits.es for the audit of
the fin8n¢ial $18temenls section of our ￿port. We are independent of the charity in 8ccord8n¢e with the ethical
requirements that a￿ relevant to our audit of the financial statements in the UK, in¢luding the FRC'S Ethical
Standard, and we havè fulfilled our other ethical rèsponsibilitiès in accordance with these r8quirements. WÉ bèli8Vè
that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Con¢luslons relatlng to golng ¢on¢¢rn
In auditing the financial statements, we have concluded that the trustees. use of the going concem basis of
accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating lo events or
conditions that, individually or collectively. may cast significant doubl on the charity's ability lo Continue as a going
ncern for a period of at least twelve months from when the financial statements ar& authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going wn¢ern are described in the
relevant seclions of this report.
Other Infomiatlon
The other information comprises the information included in the trustees. report, other than the financial statements
and our auditor's report Ihereon. The trustees are responsible for the other information contained within the trustees.
report. Our opinion on the financial statements does not cover the other information and, except to the exlenl
olheTwise explicitly ststed in our report, we do not express any form of assurance conclusion Ihereon.
Our responsibility is lo read the other information and, in doing so, considtrr whtrlher the other information is
materially inconsistent with the financial statements or our knowledge obtained in the wurse of the audit or
otherwise appears to be materially misstated. If we identify SLJch material inconsistencies or apparent material
misstatements, we are required to detemiine whether this gives rise to a material misstatement in the financial
statements themselves. If, based on the work we have performed, we conclude that there is a material
misslatemenl of this other information, we are required to report that fact.
We have nothing to report in this regard.

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
INDEPENDENT AUDITOR'S REPORT {CONTINUED)
TO THE TRUSTEES OF THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
Matters on which we are required to report by exception
We have nothing lo report in respect of the following matters in relation lo which the Charities (Accounts and
Reports) Regulations 2008 and the Charities Accounts Iscotlandl Regulation5 2006 require us lo report to you if, in
our opinion..
the information given in the financial statements is inconsistent in any material respect with the trustees,
report,. or
the charity has not kept adequate and proper accounting records., or
th8 financial statéments aré not in agrèèment with the accounting rècords and rgturns- or
we have not re￿iVed all the information and explanations we require for our audit.
Responsibilities of trustsas
As explained more fully in the Iruslees. responsibilities statement sel out on page 9, the trustees are responsible for
the preparation of the financial ststemenls and for being satisfied that they give a true and fair view, and for such
intemal control as the trustees determine is ne￿$s￿ry to enable the p￿paratIOn of financial slalemenls that are free
from material misslalemenl, whether due to fraud or orror.
In preparing the financial statements, the trustees are responsible for assessing the charity's ability to continue as a
going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic
altemalive but lo do so.
Auditor's responsibilities for the audit of the financial statements
Vve have been appointed as auditor under section 144 of the Charities Act 2011 and section 441111¢) of the Charities
and Trustee Investment (Scollandl Act 2005 and report in accordance with regulations made under these acts.
Our objectives are to obtsin reasonable assuran￿ about whether the financial slalements as a Who￿ are free frorn
alerial misslalement, whether due lo fraud or error, and lo issue an 8uditorfs report that includes our opinion.
Reasonable assurance is a high level of assurance bul is not a guaonlee that 8udil conducted in 8¢cord8n
with ISAS IUKI will always detect a material misstatement when it exists. Misststemenls Can arise from fraud or
érror and aré considerèd material if, individually or in th8 aggregate, they could reasonably bè èxp8Ct8d to influencè
the economic decisions of users taken on the basis of these financial statements.
Irregularities, in¢lLJding fraud, are inStsn￿$ of non-¢omplIan￿ with laws and regulations. We design procedures in
line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities. including
fraLJd. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Ext&nt to whi¢h th& audit was ¢on$ldored Capable of detecting irregularitl¢$
We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error,
and then design and perform audit procedures responsive lo those risks, including obtaining audit evidence that is
sufficient and appropriate lo provide a basis for our opinion. However, responsibility for the prevention and detection
of fraud ultimately rests with both those charged with governance and management of the charity.
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-
compliance with laws and regulations, our procedures included the following".
obtsining an understanding of the legal and regulatory framework applicable lo the charity by considering the
nature of the industry in which the charity operates and enquiring of management,. and
identifying the key laws and regulations considered lo have a direct impa¢t on the financial slatamtrnts
including the UK Charities A¢t 2011, Charities and Trustee Investment IS¢otlandl Act 2005, UK Generally
A¢¢epted AccoLJnting Practice and UK tax legislation., and
assessing how the charity is complying with the applicable legal and regulatory framework by making further
enquiries of management and observing the charitys control environment regarding compliance with
regulations and fraud prevention., and
assessing the susceptibility of thé charity's financial statèmènts to material misstatement, induding how fraud
might occur, by considering the effectiveness of the charily's accounting systems and controls and h)w these
were monitored by managemenl. Where Ihe risk Df material misslalement was considered to be higher in
certain areas, further audit procedures were designed to address this increased risk., and
12

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE TRUSTEES OF THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
discajssing arnongst the engagement team and fra￿j mvJhl ooxr in the finandal ststemenl8 and
any wJt8ntial indicators of fraud.
Audlt mpon•o to rl•k• of Irr•gularltl•¥ Identlfi
Oui proceduTes lo respond to risks idtrnts.fied induded the fdhJwlThJ."
rfomiing audit work over revenug rgc4)gnition inthding anatybcal wocgdures and subslanlive le8t8 of detad
of a Samp￿ of rO￿lly¥ Iranso¢tk)ns", and
rovi￿1n9 finanual statem￿1 dtsch)$ure$ * lestvw lo supwting d0￿Mental￿ lo asse88 tsjmpliance wrfh
applicatAe laws and regulations.. and
enquiry of ¢harity stsff r•sponsth for c*ymplian¢• to idontify any in$tan¢•$ of non-¢ompliance wth laws and
regulatlons.. and
&nquiry of mana9ement, IW charyod with goI￿an￿ and othfjr rel8¥onl parties around actual and
lenlial lrftyalion dalms; and
revigwing minutes of me&lings of th088 tharged with govemanc8.' arml
performing audit work over the risk of manag8ment ove￿Ide of controls. indudlng testing of Soumal entrfes and
oth8r adjuslmenls for appropriateness, •valuating the business rat￿ale of signrfunt transa￿lon5 outside the
nomlal course of business and revbthying ac¢ountmg estimates for bia$', and
eommLtnicating ￿en￿rIed I￿S and r￿ulationS and potential fraud risks to all 8ngag8mgnl l•¥m momb8r6 and
8ssessing wh&lher there are any indicalions of fr8ud Of nOr￿(%)mpliancfj wlth 18ws 8nd regulations IhroughoLrt
thè audil.
Because of the inherent l1rn1tat￿ns ol an audit. there is a risk that we will not detect all irregularitlos, indudkng tho86
18ading to a material misslalement in the finanaal statements or non-compkn'ance with r8gulatKJn. This risk inffta5es
the more that complian¢8 with a law or régulation 1$ r•moved from th8 evènts and transa¢lions reflected In Ihe
financial slal¥menl$, as ￿ w￿1 be less likety lo b￿rne aware ol instan￿$ of t)owompliance. The risk is also
preatèr regarding irregul8ri1*s occurmg due lo fraud r¥th¢f than error, a$ fraud involves intenlional concA•alm8nt,
forgery, ¢dlu8th). Omiss￿ or misrtprèsentation.
A furth•r des¢riplion of our r8$ponsibilrtie$ 1$ availab￿ on Financial Reporling Coun¢M'$ websttt 8t.. https'.11
￿￿.fr¢.0rq.Ukla￿￿rt￿sl8Spons￿l1ths. This des¢riplw fwms part of our oudrtorf$ rgport.
U•• of our r•port
This report is made sdety to the tharity's Irusttts, as a botty, in accordance wlih Part 4 of the Ch8rtties IA¢counl$
and Reports) Regulations 2008, and Regu￿￿on 10 01 th8 Charit￿S A¢counts IS¢oUandl R•gulations 2(£fj. Our
audit work h#5 been undertaken so that we might $tste lo thg charrtl$ Iru$lee$ those matters we are required lo
state lo them in an audilots. report 8nd for no other pu￿4>60. To th& lull&sl extent pemitted by IWH, wa do nol accept
or assume responsibilty to anyone other than charity aThl Ihe than￿8 trusl•es as a body. for our audlt wort. for
this report. or for the opini
N•wby Ca•tl•m•n LLP
Chartered Accountants
Slatulory Auditor
Wesl Walk BuihJir4J
110 Regent Road
Leicester
LE1 7LT
27 August 2024
N￿bY Caslleman LLP is eligit4e to ad as an auditor in lern5 of sedion 1212 of the CompaniesA¢t 20￿.
13-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 DECEMBER 2023
Unrestricted Restricted
funds
funds
2023
2023
Total
Total
2023
2022
Notes
Income from..
Donations and legacies
Charitable activities
Inveslrnenls
752,941
352,395
56,177
2,047,741
5,270,059
2,800,682
5,622,454
56,177
1,897,074
6,408,766
5,935
Total
1,161,513
7,317,800
8,479,313
8,311,775
Expenditure on..
Raising funds
Charitable activities
311,783
950,732
36,224
6.352,919
348,007
7,303,651
377,048
7,396,887
Totsl
1,262,515 6,389,143
7,651,658
7,773,935
Net lexpenditurellincome for the yearl
Net movement In funds
1101,0021
928,657
827,655
537,840
Re¢onciliation of funds
Total funds brought forn￿ard
490,960
1,969,937
2,460,897
1,923,057
Totsl fund$ ¢arrled forward
389,958
2,898,594 3,288,552
2,460,897
14

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
BALANCE SHEET
ASAT 31 DECEMBER 2023
2023
2022
Notes
Fixed assets
Tangible 8ss&ts
14
31,004
42,486
Current assets
Stocks
Debtors
Cash al bank and in hand
1S
16
55,061
5,373,880
5,105,709
53,029
4,922,609
4,025,410
10,534,650
9,001,048
Llabllltles
Creditors.. amounts falling due within one
year
17
14,893,8191
13,967,898)
Net current assèts
5,640,831
5,033,150
Totsl assets less Current 118bllltles
5,671,835
5,075,636
Creditors- amount5 falling due after
more than one year
18
12,383,283)
12,614,739)
Total nat assets
3,288,552
2,460,897
The funds of the charity
Reslricled funds
Unrestricted funds
20
21
2,898,594
389,958
1,969,937
490,960
Total ¢harity fund$
3,288,552
2,460,897
16-08-2024
The finanaal statements were approved and authorised for issue by the board of trustees on
are signed on its behalf by..
and
Dow$￿￿•d by..
'29D0￿F￿LlrfjIJ￿"
David Oxnam (Chair of Board of Trusleesl
Trustee
The notes on pages 17 - 31 fomi part of these financial statements.
15-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2023
2023
2022
Note
Cash flows from operating activities
Cash generated fromll8bsorbed byl
operations
26
1,026,714
113,5271
Investing activities
Purchase of tangible fixed assets
Investment income re￿iVed
12,5921
56,177
114,1131
5,935
Net cash generated fromllused in)
investing activities
53.58S
18,1781
Net cash used in financing activities
N¢t In¢r¢a$&lld¢¢rease} In ¢a$h and ¢ash
equlvalonts
1,080,299
121,7051
Cash and cash equivalents at beginning of year
4,025,410
4,047,115
Cash and cash equivalents at end of year
5,105,709
4,025,410
16

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
Accounting policies
Charity infomiation
The Children's Cancer and Leukaemia Group is govemed by ils Constitution.
1.1 Basis of preparation
The charity is a public benefit entity as defined by FRS102. These financial stalernenls have been prepared in
accordance with.. The Financi81 Reporting Stsndard applicable in the United Kingdom and Republic of Ireland
I'FRS 102,1, A¢¢ounling and Reporting by Charities.. the Statement of Recommended Pra¢lice for charities
applying FRS 102 120191, the Charities Act 2011, the Charities and Trustee Investment (Scotlandl Act 2005,
and UK Generally Accepted Accounting Practice.
Th& financial ststemenls are prepared in steding, whi¢h is the fun￿lonal ¢urren¢y of the ¢harily. Montrtsry
amounts in these financial statements are rounded to the nearest £.
Th& financial stslements have ￿en prepartrd under the historical cost convention. The principal accounting
policies adopted are sèt out bglow. These policies havg been Consistently appligd.
1.2 Going Goncern
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity
has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees
continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3 Charitable funds
Unrestricted fLJnds are available for use at the discretion of the trustees in furtherance of their charitable
objectives unless the funds have been designated for other purposes.
Restricted funds are funds which are to be used in accordan￿ with specific reslriclions imposed by donors or
which have been raised by the charity for particular purposes. The cost of raising and administering such
funds are charged against the specific fund. The aim and use of each reslricled fund is sel out in the notes lo
the fin8n¢i81 ststemenls.
1.4 Income recognition
Income is recognised when the charity is legally entitled to il after any performance conditions have been rnet,
the amounts can be measured reliably, and it is probable that incorne will be re￿ived.
Cash donations are re¢ognised on re¢gipt. Other donations are re¢ognis¢d once the charity has been notified
of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in
relation to donations received under GiftAid or deeds of covenant is recognised at Ihe time of the donation.
For legacies, income is recognised and included in the financial statements when all of the followng criteria
are mel..
the charity has enlitlernenl lo the funds.,
any performance conditions 8118ched lo the ilemlsl of income have been mel or are fully within the
control of the charity.,
th8r8 is sufficient certainty that receipt of the income is considarèd probable," and
the amount can be measured reliably.
Where legacies have been nolified to the charity but the criteria for income recognilion have not been met,
then the legacy is treated as a contingent asset and disclosed if material.
Government grants are recognised al fair value when the charity has entillemenl after any performance
onditions have been mel, rt is probable that the Income will be received and the amount can be measured
with reliability. If enlilltrment is not met, then the amounts are deferred.
17-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Accounting policies
(Continued}
Income from charitable activities includes income received from grants, registration fees for meetings,
member subscriptions and publication payments. Such income is recognised al fair value when the charity
has entitlement after any performance conditions have been mel, il is probable Ih8t the income will be
ceived and the amount Can be measured with ￿lIabIlIty. If enlidement is not mel, then the amounts are
deferred.
Inveslment income is earned through holding assets for investment purposes. It comprises bank interest and
is recognised on an accruals basis.
1.5 Expenditure recognition
All expenditure, including the awarding of grants, is accounted for on an accruals basis and has been
classified under headings that aggregate all costs relating to the category. Expenditure is recognised when
there is a legal or constructive obligation to make payments to third parties, it is probable that settlement will
be required and the amount of the obligation can be measured reliably. It is recognised under the following
headings..
Costs of raising funds includes costs incurred in seeking donations, grants and legacies. website
costs and advertising.
Expenditure on charitable activities includes iesearch, edu¢81ional activities and professional
association activities lo further the dglivery of the obje¢liv&s of the charity.
1.6 Support costs
Support costs are those that assist the work of the charity bul do not directly represent charitable activities
and costs of raising funds and include office costs, governance costs 8nd adminislr8tive payroll costs. They
are incurred directly in support of expenditure in line with the objectives of the charity. Support costs are
allocated lo costs of raising funds and expenditure on charitable activities on a basis consislenl with use of
th8 resourcès.
The analysis of these costs is included in note 10.
1.7 Tangible fixed assets
Tangible fixed assets are measured at cost. net of depre¢iation and any impaimient losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives
on the following bases..
Computer equipment, furniture and fixtures
5-10 years
1.8 Stocks
Stocks include merchandise stock and educational literature. Stocks that are held for resale are stated at the
lower of cost and estimated selling price. Stocks held for distribution as part of the charity's act'vilies are
valued al their service potential, which the charity considers lo be the cost of the materials.
1.9 Cash and cash equivalents
Cash and cash equiv8lenls include cash in hand, deposits held at call with banks, other short-temi liquid
investments with original maturities of three months or less.
1.10 Financial instruments
Financial instruments are recognised in the charity's balan￿ sheet when the charity becomes party to the
contractual provisions of the inslrument.
Debtors and creditors with no slated interest rate and receivable or payable within one year are measured at
transaction price. Any losses arising from impairment are recognised in the Statement of Financial Activities.
18-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Accounting policies
(Continued}
1.11 Employee benefits
When employees have ￿ndered service to the Charity, short-term employee benefits to which the employees
arè entitled are recognised at thè undiscountèd amount expected to be paid in exchangè for that servica.
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are
received.
Termination benefits are recognised immediately as an expense when the charity is demonstrably committed
lo terminate the employment of an employee or lo provide lerminalion benefits.
1.12 Retirement benefits
Payments lo defined contribution retirement benefit schemes a￿ charged as an expense as they fall due.
Critical accounting estimate5 and judgements
In the application of the charity's accounting policies, the trustees are required lo rNake judgements, estimates
and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other
SoUr￿s. The estimates and associated assumptions are based on historical experien￿ and other factors that
are considered to be relevant. A¢tual results may differ from these eslimales.
The estimates and underfying assumptions are reviewed on an ongoing basis. Revisions to a¢¢ounting
estimates are recognised in the period in which the estimate is revised where the revision affects ￿lY that
period, or in the period of the revision and future periods where the revision affects both current and future
periods.
Key sources of estimation uncertainty
The eslimales and assumptions which have a significant risk of causing a material adjustment lo the carrying
amount of assets and liabilities are as follows..
Allocation of support costs
Th& allo¢alion ol support costs is sensitivé to ¢hangÈs in th8 lèvel of work undèrtakén on each aetivity by the
¢harily. The allocation is reassessed annually and amended when ne¢essary lo reflect Current eslimales.
Income from donations and legacies
Unrestricted Restricted
funds
funds
2023
2023
Total Unrestricted
funds
2022
Restricted
funds
2022
Total
2023
2022
Donations
Legacies
622,960
129,981
703,031
1,000
1,325,991
130,981
574,290
222,369
825,676 1,399,966
33,417
255,786
752,941
704,031
1,456,972
796,659
859,093
1,655,752
19-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Income from charitable activities
Unrestricted Restricted
funds
funds
2023
2023
Total Unreslricled Restricted
funds
funds
2022
2022
Total
2023
2022
Règistration fèes for meetings
and other project expenditLJre
Member subscriptions and
publication payments
Grant in¢ome for research and
operations
CLIC Sargent chief nurse
funding
126,757
28,299
1 $5,056
90,942
18,244 109,186
153,279
153,279
162,715
162,715
72,359 6,506,385 6,578,744
93,509 6,205,417 6,298,926
79,085
79,085
79,261
79,261
352,395 6,613,769 6,966,164
347,166 6,302,922 6,650,088
Income from Invèstmènts
Unrestricted
funds
2023
Total Unrestri¢ted
funds
2022
Total
2023
2022
Interest
56,177
56,177
5,935
5,935
Expendlturè on ralslng funds
Unrestrlcted Restrl¢ted
funds
funds
2023
2023
Total Unrestricted
funds
2022
Restricted
funds
2022
Total
2023
2022
Fundraising platform fees
Website
Fundraising, marketing
and PLJblicity costs
Support costs Inote 101
30,237
3.567
30,237
13,041
24,576
2,077
24,576
2,077
9,474
110,813
167,166
26,750
137,563
167,166
188,604
161,791
188,604
161,791
311,783
36,224
348,007
377,048
377,048
20-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Expenditure on charitable activities
Activities
undertaken
directly
Note 8
Grant
fundlng
Support
Costs
Total
2023
Total
2022
Note 9
Note 10
Support for research
Informalion for patients and families
Improving treatment and care
244,693 5,963,846
72,837
318,319
173,166 6,381,705 6,613,379
258,514
331,351
299,845
272,276
590,595
483,663
635,849 5,963,846
703,956 7,303,651
7,396,887
Unrestricted funds
Restricted ftjnds
950,732
872,045
6,352,919 6,524,842
7,303,651
7,396,887
Exp¢ndltur• on a¢tlvltles undertaken dlrectly
Support for Information
Improving
research for patients treatment
and famlll•s
and car•
Total
2023
Total
2022
Staff costs
Other tumour specific expenditure
Contact magazine expenses
other publication expenses
Website
Cost of meetings
Travel expenses
Membership support Costs
Olher expenses
189,557
42.095
189,557
42,095
21,107
32,169
52,163
266,303
13,906
11,767
6,782
97,944
10,530
20,360
28,312
8,311
192,068
11,729
12.453
6,728
21,107
32,169
19,561
13,041
19,561
266,303
13,906
11,767
6,782
244,693
72,837
318,319
635,849
388,435
21

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
Expenditure on grant funding
Support for
research
Total
2023
Total
2022
Grants to institutions..
University of Birmingham
Newcastle University
UCL Institute of Child Health
University of Sheffield
University of Nottingham
University of Bristol
Queen's University Belfast
University of Southampton
University of Glasgow
University of York
University of Cambridge
Institut6 of Cancer Research
University of Leeds
University of Manchester
University of Oxford
University College Cork
University of Lei¢ester
Bimiingham Children's Hospital
King's College London
The Open University
Brunel University London
Leeds Teaching Hospi181s NHS Trust
University of Edinburgh
University of Sussex
University of Liverpool
Imperial College London
942,299
437,890
409,691
213,725
287,497
321,339
942.299
437,890
409,691
213,725
287,497
321,339
939.992
1,146,110
991,135
432,059
401,433
13,9251
222,463
124,806
559,734
248,355
494,146
96,468
222,463
124,806
559,734
248,355
494,146
96,468
140,420
317,285
325,179
210,885
357,187
11,0771
33,854
199,399
52,097
199,399
52,097
112,515
53,277
850,659
29,909
352,568
104,631
175,990
249,969
170.788
299,991
352,568
104,631
175,990
249,969
170,788
299,991
5,963,846
5,963,846
6,336,897
The charity awards grants for specific research projects to various institutions, as part of their charitable
activities.
Negative amounts represent an underspend on grants previously made, retumed lo CCLG.
22-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
10 Expenditure on support costs
Basis of allocation
2023
2022
Staff costs
Deprecialion & loss on disposal
Occupancy expenses
Postage
Staff training
Professional fees
653,872
14,074
143,429
14,253
10,205
35,289
656,900
13,069
120,538
14,789
3,658
24,392
'11-2
871,122
833,346
Analysed between
Raising funds
Charitablè activitias
167,166
703,956
161,791
671,555
871,122
833,346
.1 Support Costs, excluding goveman¢e costs, have bgen allo¢ated as follows:
Cost of raising fvnds
Charitable activilies
Support for research
Information for patients and families
Improving Irealmenl and care
20°/.12022- 20 /.)
30°/.12022- 30 /.)
30°/.12022- 30 /.)
.2 Professional fees include governance costs of £35,289 12022 - £24,392). Governance costs have been
allocated as follows..
Charitable 8ctNvitNes
Support for research
Information for patients and families
Improving treatment and care
17¢/012022 . 17Q/ol
61°/o12022- 61 /ol
The amount charged to the SOFA in respect of auditorfs remuneration was..
statutory audit £9,78012022- £9,300)
other services £98912022- £1,2531
11 Taxatlon
The charity is exempl from tsxation on ils a¢livilies because all its income is applied for charitable purposes.
12 Trustees
None of the trustees lor any persons wnnecled with them) received any remuneration or benefits during the
year.
-23-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
13 Employees
The average monthly number of employees during the year was..
2023
Number
2022
Number
Total
22
22
Employment ¢ost$
2023
2022
Wages and salaries
Social security costs
Other pension costs
709,013
68,378
66.038
633,405
63,204
58.235
843,429
754,844
The number of employees whose 8nnual remuneration (including pension
contribulionsl was more than £60,000 is as follows..
2023
Number
2022
Number
£60,001 - £70,000
£70,001 £80,000
£80,001 - £90,000
£90,001- £100,000
£100,001- £110,000
Remuneration of key management personnel
The remuneration of key management personnel, is as follows.
2023
2022
Aggregate Compensation
272.052
253,428
-24-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
14 Tangible fixed assets
Computgr
equipment,
furniture
and fixtures
Totsl
Cost
Al 1 January 2023
Additions
87,438
2,592
87,438
2,592
Al 31 December 2023
90,030
90,030
Depreciation and impairment
Al 1 January 2023
Depreciation charged in the year
44,952
14,074
44.952
14,074
At 31 December 2023
59,026
59,026
Carrying amount
Al 31 December 2023
31,004
31,004
Al 31 De¢&mber 2022
42,486
42,486
15 Stocks
2023
2022
Merchandise stock
Educational literature
31,790
23,271
30,263
22,766
55.061
53.029
-25-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
16 Debtors
2023
2022
Amounts falllng due wlthln one year:
Trade debtors
Grant deblors
Rent deposit
Prepayments and a￿rUed income
Accrued legacy income
19,656
3,512,427
16,200
150,076
138,500
7,833
2,830,745
16,200
155,731
172,500
3,836,859
3,183,009
2023
2022
Amounts falling due after more than one year..
Grant debtors
1,537,021
1,739,600
Total debtors
5,373,880
4,922,609
17 Crèditors= amounts falling duè within onè yèar
2023
2022
Deferred income
Tradè c￿dItorS
Grant creditors
Accruals
19,559
16,316
4,821,058
36,886
100
17,056
3,911,669
39,073
4,893,819
3,967,898
Deferred incorne includes income received in respect of meetings postponed until the next financial year.
18 Creditors: amounts falling due after more than one year
2023
2022
Grant c￿dItorS
2,383,283
2,614,739
19 Retirement benefit schemes
Defined contribution schemes
The charity operates a defined contribution pension scheme for all qualifying employees.
The amount recognised in unrestricted expenditure was £66,03812022- £58,235).
26-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
20 Restricted funds
The income fvnds of the charity include reslricled funds which comprise the following unexpended balances of
donations and grants held on trust for specific purposes..
Movement In funds
Income
Expenditure
Balance at
1 January
2023
Transfers
Balance at
31 December
2023
Tumour specific funds
CCLG Prize
General research ftjnd
Adam Hay fund
CCLG Senior Members Group
PODC
POTG
The Little Princess Trust fund
Treatmenl Guidelines fund
TYAC Lisa Thaxler
Child Cancer Smart
PORT
CCLG Research Network
Partner Charity
Neuroblastoma Nursing Group
PODC- Iraq Fund
Young Lives vs Can¢er Chief
Nurse Funding
Health Information
TYAC General Restricted
TYAC Research
Projeds Reslricled Fund
1,573,167
364
3,180
11,222
805,435
1773.3091
1,605,293
364
5,670
11,262
2,49C>
40
5.896
954
10,980
6,200 4,510,486
614
36,632
38,105
420
6,850
2,156
6,200
614
21,632
37,786
420
18,8041
14,510,486)
115.0001
13191
652,188
1652,1881
19,0001
10,500
8,384
1,500
9,694
1,310
5.948
16,920
1,000
66,000
496
185,378 1,237,832
83,309
12,300
186,9251
112,3001
2,332
16,920
1,000
66,496
1,102,398
1320,8121
1,969,937 7,317,800
16,389.1431
2,898,594
-27-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
20 Restricted funds
(Continued}
Movement in funds
Income
Expenditure
Balan¢e at
1 January
2022
Transfers
Balance at
31 Dècèmbèr
2022
Tumour specific funds
CCLG Prize
General research fund
Adam Hay fund
CCLG Senior Members Group
PODC
POTG
The Little Princess Trust fund
Treatment Guidelines fund
TYAC Lisa Thaxter
Child Cancer Smart
PORT
CCLG Research Netr￿ork
Partner Charity
Neuroblasloma Nursing Group
PODC- Iraq Fund
Young Lives vs Cancer Chief
Nurse Funding
Health Infomiation
TYAC General Reslricled
TYAC Research
Projects Restricted Fund
1,112,573
761,793
310
2,000
120
1301,1991
1,573,167
364
3,180
11,222
3,940
11,102
{2,7é01
4,782
1,114
210
8,350
6,200 5,639,6é9
18,225
44,132
72,867
420
5,896
{9,7371
15,639,669)
117,6111
{7,5001
139,7621
1,177
6,200
614
36,632
38,105
420
5,000
42,467
10,500
4,108
324,425
1366,8921
10.500
8,384
4,276
79,261
27,375
1,000
66.000
241,322
173,3131
110,4551
5,948
16,920
1,000
66.000
185,378
155,9441
1,331,587 7,162,015
16,524,842)
1,177
1,969,937
Transfers have been made into reslricled funds from unrestricted funds lo underwrite a ￿sh deficit on a fund.
Tumour spe¢lfi¢ funds
Represents income received from donors with a specrfic request that the funds are used in support of grants
for a particular tumour type.
CCLG Prize
Represents income received from donors to fund the CCLG Prize.
General research fund
Represents income received from donors wth a specific request that the funds are used for research
purposes.
Adam Hay fund
This fund has been established to continue work done by the Adam Hat's charity (which merged with CCLG in
20111 in neuroblastoma research and psychological support for children and families.
CCLG Senior Members Group
Represents income received from the Senior Members. Group lo be used for their aclivilies.
-28-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
20 Restricted funds
(Continued}
PODC
Represents income re￿Ived frorn donors lo be used for the Paediatric Oncology in Developing Countries
IPODCI.
POTG
Represents income received from donors to be Ljsed for the Paediatric Oncology Trainees, Group IPOTGI.
The Little Princess Trust fund
Represents income received from The Little Prin￿SS Trust to fund future instalments of research grants
awarded.
Treatment Guidelines fund
Represents a grant received for the development of rare endocrine tumour guidelines.
TYAC Llsa Thaxter
Represents income received for providing and supporting education and training to professionals working in
the field of teenage and young adult cancer. This was previously a restricted fund in TYAC and has transferred
to CCLG as part of the closure of fiAC, with the same restrictions maintained.
Child Cancer Smart
Represents income received for a research programme, guideline development and awareness raising
focusing on earlier diagnosis of childhood cancer.
PORT
Represents income received for the Paediatri¢ Oncology Reference Team, a group of parents of children with
cancer who review clinical trial and other ￿SearCh information to ensure it is appropriate for chikjren with
cancer and their families.
CCLG Research Network Partner Charity
Represents income research from other charities lo fund research projects.
Neuroblastoma Nursing Group
Represents income received lo support the Costs of running the national neuroblastoma nursing group, a
group of CCLG member nursos with a special interest in neuroblasloma.
PODC- Iraq Fund
Represents donations received lo specifically support work to improve the treatment and care of children with
cancer in Iraq.
Young Lives Ys Cancer Chief Nurse Funding
Funding for the Chief Nurse role and associated projects.
Health Information
Funds received to support the production of health information for patients and families.
TYAC G&noral Rèstrictod
Fundraising and donations to support work specifically for teenagers and young adults with cancer.
AC Research
Income reslricled to support research projects into teenage and young adult Can￿r.
Projects Restricted Fund5
Income reslricled to support specific projects including work related to research.
-29-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
21 Unrestricted funds
Movement in fvnds
In¢om¢ Expendlture
Balance at
1 January
2023
Transfers
Balance at
31 Decémbèr
2023
Genoral funds
490,960
1,161,513 11,262,515)
389,958
Movement in fvnds
Incom¢ Expendlture
Balance at
1 January
2022
Transfers
Balance at
31 Decembèr
2022
Genoral funds
591.470
1,149,760 11.249.093)
11,1771
490.960
22 Analysis of net assets between funds
Unrestrl¢ted
funds
2023
Restrl¢ted
funds
2023
Totsl
2023
Fund balances at 31 December 2023 are represented by..
Tangible assets
Current assetsllliabilitiesl
Long term liabilities
31,004
358,954
31,004
5,281,877
5,640,831
12,383,283) 12,383,283)
389,958
2,898,594
3,288,552
Unrestrlctèd
funds
2022
Rèstrlcted
funds
2022
Total
2022
Fund balances at 31 December 2022 are represented by..
Tangiblo assets
Current assetsllliabi1iliesl
Long term liabilities
42,486
448,474
42,486
4,584,676
5,033,150
12,614,739) 12,614,739)
490,960
1,969,937
2,460,897
23 Evènts aftar thè rèportlng datè
Thè charity was notifi￿ of an additional lagacy during th8 year. Thè timing and amount ol th8 18gacy income
is uncertain as at the balance sheet date and therefore no income relating to this legacy has been recognised
in these accounts.
30-

DoGusign Envelope ID.. A1B3A321k1BC944D9-AEBD-AE2D6F204600
THE CHILDREN'S CANCERAND LEUKAEMIA GROUP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
24 Operating lease commitments
Al the reporting end dale the charity had outstanding commitments for future minimum lease payments under
non-cancellable operating lease5, which fall due as follows..
2023
2022
Within one year
Between tr￿0 and five years
18,397
36,530
18,397
18,397
54,927
Amounts recognised in the SOFA as an expense during the period in respect of operating lease arrangements
are £36,53012022- £34,730).
25 Related party tran$a¢tlons
There have been no other related party transactions in the reporting period that require disclosure in the
financial statemènts, othèr than thosè notèd in note 12 to thè financial statements.
26 Cash generated from operations
2023
2022
Surplus for the year
827,655
537,840
Adjustments for..
Investment income recognised in $18lement of financi81 activities
Depreciation and impairment of tangible fixed asseis
156,1771
14,074
15.9351
13,069
Movements in working capitsl..
Ilncreasel in stocks
Ilncreasel in debtors
Increase in creditors
Increase in deferred income
12,0321
117,6031
1451,2711 11,153.2891
675,006
612,291
19,459
100
Cash generated fromllabsorbed by) operations
1,026,714
113,5271
27 Analysis of changes in net funds
During the year the charity had no borrowings or obligations under finan￿ leases. The changes in net funds
of the charity therefore solely comprise of cash and cash equivalents.
31